IQVIA Holdings DPO Ratio 2011-2025 | IQV

Annual DPO Ratio IQVIA Holdings

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	126	23.6	18.7	19.2	12.8	9.98	9.76	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
126	9.76	31.4

Quarterly DPO Ratio IQVIA Holdings

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11.4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4.24	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
11.4	4.24	7.83

DPO Ratio of other stocks in the Diagnostics research industry

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	120	-	-6.23 %	$ 30.6 M	Germany
DarioHealth Corp. DRIO	43.9	$ 12.08	1.6 %	$ 343 M	Israel
Akumin AKU	21.3	-	-17.87 %	$ 25.9 M	Canada
DexCom DXCM	70.4	$ 66.05	-1.36 %	$ 25.5 B	USA
Burning Rock Biotech Limited BNR	125	$ 16.21	2.92 %	$ 174 M	China
Exact Sciences Corporation EXAS	139	$ 101.54	0.04 %	$ 18.8 B	USA
Accelerate Diagnostics AXDX	125	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	56.3	-	-13.05 %	$ 7.29 M	USA
BioNano Genomics BNGO	104	$ 1.57	-2.88 %	$ 2 M	USA
Oxford Immunotec Global PLC OXFD	45.8	-	-	$ 562 M	Britain
Castle Biosciences CSTL	52	$ 38.67	0.09 %	$ 1.07 B	USA
Chembio Diagnostics CEMI	52.5	-	0.22 %	$ 16.8 M	USA
Danaher Corporation DHR	66.4	$ 226.56	0.1 %	$ 166 B	USA
Fulgent Genetics FLGT	34.9	$ 26.89	-0.92 %	$ 813 M	USA
Global Cord Blood Corporation CO	17.7	-	-	$ 399 M	China
Fluidigm Corporation FLDM	61.4	-	1.08 %	$ 308 M	USA
Mettler-Toledo International MTD	53.4	$ 1 410.21	1.19 %	$ 29.9 B	Schweiz
Genetic Technologies Limited GENE	780	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	43.5	-	0.12 %	$ 80.1 M	China
NeoGenomics NEO	20.7	$ 12.03	1.52 %	$ 1.52 B	USA
Neogen Corporation NEOG	62.7	$ 6.79	-1.02 %	$ 1.47 B	USA
DermTech DMTK	47.4	-	-11.32 %	$ 2.94 M	USA
PRA Health Sciences, Inc. PRAH	8.98	-	-	$ 10.7 B	USA
CareDx, Inc CDNA	44.2	$ 19.88	-3.31 %	$ 1.07 B	USA
Enzo Biochem ENZ	52.3	-	-8.98 %	$ 14.8 K	USA
Pacific Biosciences of California PACB	33.5	$ 2.12	-	$ 538 M	USA
Anixa Biosciences ANIX	1.29 K	$ 3.32	-7.26 %	$ 106 K	USA
Co-Diagnostics CODX	106	$ 0.31	-9.29 %	$ 9.1 M	USA
Precipio PRPO	53	$ 24.67	-1.2 %	$ 32 M	USA
Quidel Corporation QDEL	101	$ 28.84	0.14 %	$ 1.21 B	USA
QIAGEN N.V. QGEN	50	$ 45.08	-0.31 %	$ 10 B	Niderland
Guardant Health GH	83.6	$ 103.85	1.74 %	$ 12.7 B	USA
Aspira Women's Health AWH	112	-	-6.19 %	$ 10.5 M	USA
Sotera Health Company SHC	46.2	$ 16.84	0.03 %	$ 4.76 B	USA
Soleno Therapeutics SLNO	130	$ 49.87	-4.1 %	$ 2 B	USA
Heska Corporation HSKA	39.7	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	112	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	56.3	$ 134.53	-0.25 %	$ 21.4 B	USA
Charles River Laboratories International CRL	24.5	$ 197.25	2.19 %	$ 10.1 B	USA
Thermo Fisher Scientific TMO	49.3	$ 572.13	0.08 %	$ 219 B	USA
Trinity Biotech plc TRIB	163	$ 0.96	-10.3 %	$ 61.9 M	Irlanda
Quotient Limited QTNT	86.2	-	-11.32 %	$ 1.1 M	Schweiz
Twist Bioscience Corporation TWST	12.5	$ 31.04	0.36 %	$ 1.86 B	USA
Quest Diagnostics Incorporated DGX	18.3	$ 184.03	0.81 %	$ 20.4 B	USA
Myriad Genetics MYGN	42	$ 6.98	-3.26 %	$ 632 M	USA